Year-End Amendment

LATHAM & WATKINS LLP for AMPHASTAR PHARMACEUTICALS

Firm
Client
Income
$20,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
Year-End Report Feb 13, 2008 $20,000 Replaced
Year-End Amendment (this page) Apr 16, 2008 $20,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Congressional oversight of the Food and Drug Administration and Environmental Protection Agency EPA rulemaking on CFC propellants

LobbyistCovered position, as disclosed
J BENNEVILLE HAAS —
JOHN MANTHEI N/A
ROBERT M SUSSMAN —

Contacted: UNDETERMINED; Food & Drug Administration (FDA); Environmental Protection Agency (EPA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.